EP3348258
Samsetningar af tetrasýklínefnasamböndum til töku um munn og til inndælingar
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
30.3.2009EP published:
9.9.2020EP application number:
18158017.6
EP translation filed:
6.10.2020Grant published:
15.10.2020EPO information:
European Patent Register
Max expiry date:
29.3.2029Expiry date:
29.3.2027Next due date:
31.3.2027
Title:
ORAL AND INJECTABLE FORMULATIONS OF TETRACYCLINE COMPOUNDS
Timeline
Today
30.3.2009EP application
9.9.2020EP Publication
6.10.2020Translation submitted
15.10.2020Registration published
29.3.2027Expires
Owner
Name:
Paratek Pharmaceuticals, Inc.Address:
75 Park Plaza 4th Floor, Boston, MA 02116, US
Inventor
Name:
JOHNSTON, SeanAddress:
Doylestown, PA Pennsylvania 18901, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
40398 PDate:
28.3.2008Country:
US
Classification
Categories:
A61K 9/00, A61K 9/20, A61K 31/65, A61P 31/04
Annual fees
Number
Paid
Expires
Payer
Number: 13
Paid: 2.3.2021
Expires: 29.3.2022
Payer: Sigurjónsson & Thor ehf.
Number: 14
Paid: 2.3.2022
Expires: 29.3.2023
Payer: Patice ehf.
Number: 15
Paid: 9.3.2023
Expires: 29.3.2024
Payer: Árnason Faktor ehf.
Number: 16
Paid: 19.3.2024
Expires: 29.3.2025
Payer: Árnason Faktor ehf.
Number: 17
Paid: 13.2.2025
Expires: 29.3.2026
Payer: Árnason Faktor ehf.
Number: 18
Paid: 27.3.2026
Expires: 29.3.2027
Payer: Árnason Faktor ehf.